Eva Distler

Rapid identification and sorting of viable virus-reactive CD4+ and CD8+ T cells based on antigen-triggered CD137 expression

Michael Karg, Eva Distler, Abdo Konur et al. · Journal of Immunological Methods · 2008 · 90 citations

Life Sciences, Cell Biology, Immunology +17

IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype

Jana D. Albrecht, Michaela Frey, Daniel Teschner et al. · Cancer Immunology Immunotherapy · 2010 · 30 citations · Full text

Life Sciences, Immunology, Oncology +16

Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation

Eva Distler, Elke Schnürer, Eva Wagner et al. · Biology of Blood and Marrow Transplantation · 2008 · 28 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8+ CD62L(high)+ T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rγnull mice

Eva Distler, Catherine Wölfel, Sylvia Köhler et al. · Experimental Hematology · 2008 · 25 citations · Full text

Life Sciences, Hematology, Immunology +17

Nanoparticles and Antigen-Specific T-Cell Therapeutics: A Comprehensive Study on Uptake and Release

Oliver Zupke, Eva Distler, Anna Jürchott et al. · Nanomedicine · 2015 · 22 citations

Pharmacy, Immunology, Pharmaceutics +17